News »

News »

Intas Pharmaceuticals To Market Bortezomib In India – Intas Biopharmaceuticals has recently launched Borviz (bortezomib) in India for the treatment of multiple myeloma. Bortezomib is marketed in the U.S. under the brand name Velcade. The medication is given as an intravenous injection, and the dosage is based on individual medical conditions. About 3.5 million cancer cases have been diagnosed in India and statistics show that the age of onset for multiple myeloma is decreasing from the current 65 years of age. For more information about Borviz see the India PR Wire press release.

Myeloma: Understanding Drug Therapy And Stem Cell Transplantation – The Leukemia & Lymphoma Society (LLS) is sponsoring this free teleconference on May 14 from noon to 1:30 p.m. EST. Dr. Seema Singhal, Professor of Medicine and Director of the Myeloma Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, will present on the topic and take questions from participants. For more information, please visit the LLS Web site.

Honolulu Triathlon – On May 17, members of the Leukemia & Lymphoma Society’s (LLS) Team In Training program will participate in this Hawaiian triathlon. There will be both international and sprint races. For more information, please visit the LLS Web site.

News »

2009 BIO International Convention – This convention will be held from May 18 to May 21 in Atlanta, GA. Over 180 companies will visit and give presentations on their developments in technologies and other accomplishments. The convention is meant to act as a partnering tool for companies, as well as to give licensing tips and develop industry resources. For more information or to register, please visit the official BIO International Convention Web site.

2009 ASCO Meeting – The American Society of Clinical Oncology (ASCO) meeting will be held May 29 to June 2 in Orlando, FL. This meeting will include forums and exhibits on recent scientific and educational progress in oncology. A major focus at the meeting will be on personalizing health care. Registration and a registration fee are required. For more information or to register, please visit the ASCO Web site.

7th Annual Monte Carlo Night – This night of entertainment will be held on May 14 in San Francisco City Hall. The event begins at 7 p.m. and ends at 1 a.m. Proceeds from the event will benefit the Leukemia and Lymphoma Society (LLS). The price of tickets is $75. For more information, please visit the LLS Web site.

What Myeloma Patients Should Know About The Swine Flu – The Leukemia and Lymphoma Society (LLS) has compiled a list of need-to-know information about the H1N1 flu (swine flu) for patients with chronic medical conditions or those with weakened immune systems. To view this list, please visit the LLS Web site.

For a more detailed listing of myeloma-related events, please check the Myeloma Beacon Events Calendar.

News »

MMRF ‘Laugh For Life’ Fundraising Event — On May 5, the Multiple Myeloma Research Foundation (MMRF) will host the ‘Laugh For Life’ fundraiser in New York City from 6 p.m. to 9 p.m.  The event will feature dinner, live and silent auctions, and an entertaining line up of stand-up comedians.  More information, as well as ticket purchase, may be found at the MMRF Web site.

Dacetuzumab Clinical Trials Currently Enrolling — Seattle Genetics, Inc. has announced preclinical data for dacetuzumab, an anti-CD40 monoclonal antibody currently being tested for treatment of multiple myeloma and non-Hodgkin’s lymphoma. In the most recent results, dacetuzumab enhanced patient response to regimens of conventional chemotherapeutic agents, and researchers have identified a tumor mutation that helps predict which patients will respond to dacetuzumab. Two clinical trials, the first testing dacetuzumab alone and the second testing it in conjunction with Revlimid (lenalidomide) and dexamethasone (Decadron), are currently enrolling. For more information, see the Seattle Genetics, Inc. preclinical results press release.

Sign Up With LLS’s ‘Team In Training’ For The Nation’s Triathlon – On September 13, the Leukemia & Lymphoma Society (LLS) will host the Nation’s Triathlon, the only triathlon dedicated to fighting blood cancer, in Washington, D.C.  Although the event is already sold out, individuals can still participate by joining LLS’s ‘Team in Training’ (TNT) program. By signing up with TNT, participants will receive four to five months of certified coaching, race gear, and travel and lodging arrangements. For more information, see the LLS Team in Training Web site.

For a more detailed listing of myeloma-related events, please check the Myeloma Beacon Events Calendar.

News »